Four case histories are reported in which the initial signs and symptoms were those of pulmonary infiltration and in which subsequently a diagnosis of myelodysplasia was made. The analysis of bronchoalveolar lavage fluid -demonstrating predominantly neutrophils and lymphocytes, and, occasionally blast cells as well as plasma cells -indicated that the pulmonary infiltration was related to the myelodysplastic process. As no other causes of pulmonary infiltration could be found, it seems that a pulmonary infiltrate can be the presenting symptom of a myelodysplastic syndrome. Although pleuropulmonary infiltrates most often are caused by infections, these cases illustrate that myelodysplasia related infiltrates should also be considered.
/l. The erythrocyte sedimentation rate (ESR) was 82 mm in one hour. Immuno-electrophoresis demonstrated a monoclonal increase of IgG type kappa. Renal and liver functions were normal. Folate and vitamin B12 deficiency were ruled out. Moreover, serology for autoimmune diseases including auto-antibody screen, antineutrophil cytoplasmatic antibody (ANCA), serum angiotensin converting enzyme and rheumatoid factor were negative.
A chest roentgenogram showed an infiltrate of the left lower lobe with a pleural effusion, which was confirmed on a computer tomography of the chest. There was no evidence of adenopathy; thoracocentesis revealed transudative fluid, a smear negative for acid fast bacilli, no growth on cultures for bacteria, and negative cytologic stains.
Fiberoptic bronchoscopy showed no endobronchial abnormalities. Accordingly, a bronchoalveolar lavage (BAL) was performed. BAL fluid analysis disclosed an increased total cell count (28 x 10 4 /l; reference value 10.3 ± 1.5 x 10 4 /l), predominantly polymorphonuclear neutrophils (PMNs: 45%; reference 1.3 ± 0.2%) and lymphocytes (35%; reference value 11.0 ± 1.3) [1] . Moreover, some plasma cells (normally not present in BAL fluid) were found. Cell-free supernatant from BAL fluid assayed for albumin, protein and immunoglobulins revealed paraproteins of the IgG-kappa type. No bacteria were seen on Gram-stained preparations and culture of BAL fluid remained sterile.
Histological examination of material obtained by open lung biopsy demonstrated an organizing pneumonia with the appearance of many plasma cells. However, no signs of monoclonality were found. The overlying pleura was secondarily involved. No signs of a granulomatous inflammatory process or of malignancy were found. Cultures for and stains for bacteria, myobacteria, Legionella, fungi, Pneumocystis carinii, Herpes Simplex virus and Cytomegalovirus were all negative. Bone marrow examination was normal.
The diagnosis at that moment was diffuse interstitial pneumonitis of unknown origin with monoclonal gammopathy. He left the hospital after supportive treatment in a reasonable condition.
One month later he was hospitalized with similar complaints. Chest roentgenogram showed infiltrates of the right upper and left lower lobe. He still had a pancytopenia, the ESR was increased to 102 mm in one hour. Immuno-electrophoresis showed no more signs of monoclonal increase of IgG type kappa. Repeated bone marrow examination showed hypercellularity, a moderate dyserythropoiesis, 4% of blasts, 6% plasma cells, and 82% ringed sideroblasts indicating a myelodysplasia, i.e., a refractory anaemia with ringed sideroblasts (RARS). The patient was treated with supportive care consisting of packed cells transfusions intermittently as required. He died one year after the first admission. Autopsy was not performed.
Case 2
A 64-year-old man was admitted to hospital because of progressive fatigue, dyspnea, and productive cough. He did not smoke and had no medical history of note. He used no medication. The findings from physical examination were unremarkable, except for a few coarse crackles over the lower fields of the left lung.
Laboratory findings showed a pancytopenia. The haemoglobin level was 6.1 mmol/1, the haematocrit 24%. The leucocyte count was 3.0 x 1O 9 /1 with 53% neutrophils, 15% lymphocytes, 5% monocytes, 3% metamyelocytes, 2% myelocytes, 2% promyelocytes, 19% blast cells, also 8% erythroblasts per 100 leucocytes were seen. The platelet count was 197 x 10 9 /l. The ERS was 130 mm in one hour. Renal and liver functions were normal, serological tests for autoimmune diseases were negative. Folate and vitamin B12 deficiency were ruled out. A chest roentgenogram showed coarse reticular opacities of the left lower lobe (Figure 1) . A HRCT showed a diffuse reticulonodular infiltrative process in the lower lobes of both lungs (Figure 2 ). BAL fluid analysis disclosed an increased total cell count. Evaluation of the differential cell count showed in this patient the presence of monoblastic type cells accounting for 85%. In addition, the number of PMNs was increased. No bacteria were seen on Gram-stained preparations and culture of BAL fluid remained sterile.
A diagnosis of refractory anaemia with excessive blasts in transformation (RAEB-t) was made on analy- sis of peripheral blood and bone marrow biopsy. Bone marrow examination showed hypercellularity, severe dyserythropoiesis with 20% blast cells. In the peripheral blood 16% blasts were found. In conjunction with this information the cytological findings, especially the presence of leukaemic cells in BAL fluid, the pulmonary infiltrates were associated with the RAEB-t.
The patient was treated with idarubicine 19 mg intravenously (i.v.) for three days, ARA-c (cytosine arabinoside) 190 mg i.v. for 10 days and etoposide 190 mg i.v. for five days, with improvement of the roentgenographic abnormalities normalizing of the BAL fluid profile and partial remission of the RAEB (decrease of ERS to 67 mm in one hour as well as increase of haemoglobin level 6.9 mmol/1, haematocrit 0.33%, leucocyte count 4.2 x 1O 9 /1 and platelet count 222 x 1O 9 /1). However, just two weeks after this clinical improvement he was admitted again to hospital because of fever, dyspnea and tiredness. Roentgenogram of the chest showed again infiltrates in both lower lobes.
A diagnosis of acute myelomonocytic leukaemia was made by analysis of peripheral blood and bone marrow biopsy (47% blast cells). Initially, he responded to the started therapy. However, shortly after this clinical improvement his acute myelomonocytic leukaemia worsened and died from the complications.
Case 3
A 76-year-old man was admitted to hospital because of fever, weight loss (10 kg in the last five weeks), cough, dyspnea, and frequent respiratory infections in the months prior to admission. He did not smoke. Physical examination revealed severe pallor, cachexia and some inflammatory plaques which were present on both arms. A few coarse crackles were heard over both lower pulmonary lobes. The liver and spleen were not enlarged and no lymphadenopathy was present.
The haemoglobin level was 5.7 mmol/1, the haematocrit 27%, the mean cell volume 98. The white blood cell count was 11.9 x 10 9 /l with 88% neutrophils, 8% lymphocytes and 4% monocytes. The platelet count was 593 x 1O 9 /1. The ERS was 124 mm in one hour. Serology for autoimmune disease was negative, except for an atypical pANCA pattern. Both folate and vitamin B12 deficiency were ruled out.
A chest roentgenogram showed reticular opacities in both lungs which was confirmed by HRCT showing severe interstitial pneumonitis.
BAL fluid analysis disclosed a total cell count of 8.8 x 10 4 /ml with 33.8% alveolar macrophages, 4.6% PMNs, 56.6% lymphocytes with lymphoplasmoid cells, 1.0% eosinophils and 2.4% mast cells. Remarkably, cells suggestive of ringed sideroblasts were seen.
The diagnosis of a myelodysplastic syndrome, i.e., refractory anaemia with ringed sideroblasts (24%) was confirmed by bone marrow examination. Supportive treatment with packed cells transfusions when required was started.
Case 4
A 48-year-old non-smoking woman was admitted to hospital because of high grade fever, right sided pleuritic chest pain and malaise present since four days. There was no history of allergy, recent infections or medication use. Examination was unremarkable except fever of 39.7 °C, dullness to percussion and decreased breath sounds at the base of the right lung. The ESR was 126 mm in one hour; the haemoglobin level was 6.1 mmol/1; mean cell volume 104; the leucocyte count was 3.9 x 10 9 /l with 1% blast cells, 1% myelocytes, 14% band forms, 73% polymorphonuclear leucocytes, 10% lymphocytes, and 1% monocytes per 100 leucocytes. The platelet count was 93 x 10 9 /l. No signs of disseminated intravasal coagulation were found. Renal and liver function tests, vitamin B12 and folate were normal. Serological tests for autoimmune diseases were negative.
A chest roentgenogram showed pulmonary infiltrates in the right lower and middle lobes with a pleural effusion. Bronchoscopy revealed no abnormalities. Cultures of BAL fluid, sputum, blood and urine remained sterile. Cellular analysis of the BAL fluid showed an increase of the total cell count (22 x 10 4 /l), predominantly PMNs (84%). Thoracocentesis revealed an exudate with a protein content of 38.3 g/1 and a LDH content of 346 U/l. Culture of the pleural effusion failed to demonstrate an infectious process. Cytological examination revealed no signs of malignancy. At that moment, a pneumonia of unknown origin with toxic leucocyte differentiation was considered. Despite treatment with broadspectrum antibiotics, which had been started empirically, the patients clinical condition did not improve. She remained pyrexial with respiratory symptoms. One week after admittance she developed bulleous cutaneous lesions on the right and left arm. Biopsy specimen were indicative for the diagnosis Sweet's syndrome. Additionally, bone marrow biopsy was performed because persistence of toxic leucocyte differentiation showing refractory anaemia with excess of blasts. She was treated with chemotherapy (idarubicine, ARA-C and etoposide) resulting in improvement of the pulmonary and cutaneous infiltrates. However, after chemotherapy she became platelet transfusion dependent caused by high circulating HLA antibodies concentration. Despite treatment with immunoglobulin and identical platelet transfusion she died of an intracerebral haemorrhage.
Discussion
Although therapeutic advances in the management of malignant haematologic disorders like myelodysplasia have increased survival time, they have also often impaired host defence, predisposing to opportunistic infections [2, 3] . The appearance of pulmonary infiltrates is a serious complication in these patients and diagnostic procedures like BAL and sometimes even lung biopsy are required in the differential diagnosis (Table 1 ) [3] [4] [5] [6] [7] [8] [9] [10] . Intercurrent infections can be an especial problem in continuing chemotherapy which has already been the started and causes substantial morbidity. Pulmonary complications in patients with myelodysplasia may be caused by infections, heart failure, haemorrhage, chemotherapy and rarely by leukaemic infiltration of the parenchyma of the lungs [2] [3] [4] [5] [6] [7] [8] [9] [10] . The first case reports a patient who initially presented with pulmonary manifestations associated with myelodys-plasia demonstrated by features in BAL fluid profile analysis, lung biopsy as well as clinical features, before bone marrow classification was documented.
Takimoto et al. [11] reported bilateral interstitial infiltrates in a woman with refractory anaemia associated with Sweet's syndrome. At autopsy the lungs showed diffuse alveolar damage and the presence of patchy chronic interstitial inflammatory infiltrates. BAL fluid analysis revealed an increase of the total cell count, predominantly lymphocytes and PMNs, comparable with the cases described in this report. Sweet's syndrome, acute febrile neutrophilic dermatosis, is characterized by fever, leucocytosis, arthralgia, and single or multiple painful erythematous, pustular plaques of the face and upper body with good corticosteroid responsiveness [12] . Sweet's syndrome may be recurrent, it often occurs in association with other illness, 20% of patients have an underlying malignancy predominantly myeloproliferative disease. More than 50% of malignancyassociated Sweet's syndrome involve extracutanous sites especially musculo-skeletal and less frequently ocular, renal, hepatic and pulmonary [11] [12] [13] [14] . Cultures are negative and biopsy is diagnostic. Only few previous reports were found describing the association of myelodysplasia and pulmonary involvement [10, 11, 14] . The first three reported cases demonstrated neutrophilia, but no dermatosis. Case 4 presented with pulmonary symptoms followed by manifestations of Sweet's syndrome, which finally appeared to be associated with myelodysplasia. Kueh and Vijayasingam [6] also reported a patient with myelodysplasia who developed progressive Sweet's syndrome.
Acute myelomonocyte leukaemia is more likely than other subtypes of acute leukaemia to have extra medullary involvement of other tissues. The second case showed massive pulmonary infiltration by leukaemic cells already in the preleukemic phase of RAEB-t. Initially, after infections were excluded, the pulmonary manifestations improved after the initiated chemotherapy. However, the clinical condition deteriorated and the patient died. Rossi et al. [15] described a similar case with acute myelomonocytic leukaemia presenting with acute onset of fever, dyspnea and cough, in whom the diagnosis of pulmonary invasion by leukaemic cells was made by cytochemical analysis of cells obtained from recovered BAL fluid. In agreement with their findings, in this case leukaemic cells were also found in BAL fluid suggesting alveolar blastic infiltration. Initially, an improvement was demonstrated, however, not for long, since the pulmonary infiltrates were present again and he developed an acute myelomonocytic leukaemia, and, finally died.
The roentgenographic features are nonspecific, depending on the severity of involvement and acuteness of onset, these features can easily be confused with pneumonia or lymphangitis carcinomatosa. Some case reports were found describing respiratory failure with advancing interstitial pulmonary diseases on chest X-ray caused by pulmonary interstitial extramedullary haematopoiesis associated with myelofibrosis [4, 5] . Matsushima et al. [16] suggested the involvement of immunologic abnormalities in the pulmonary disorders of three patients with myelodysplastic syndromes with chromosomal abnormalities. Diffuse expansion of the pulmonary interstitium by more or less mature lymphocytes and plasma cells -as demonstrated by BAL fluid analysis in the reported cases -support this suggestion of derangement of the immune function. Immunologic abnormalities are frequently seen in myelodysplastic syndromes. Abnormalities in B cells, T cells, natural killer cells, and monocytes have been reported, as well as a polyclonal rise in serum immunoglobulin [11, 12, [17] [18] [19] .
In conclusion, these cases illustrate that the presented pulmonary infiltrations were associated with myeloproliferative disorders prior to the final diagnosis. Therefore, in patients with pulmonary disorders associated with myelodysplasia immunosuppressive therapy with steroids should be considered, especially when antibiotic treatment is not effective and infections are excluded.
